A roundtable discussion on what clinical evidence may look like in the future. Moderated by Dr Mark Hibberd, CMO, GE Healthcare. The symposia will feature three presentations, followed by a LIVE Q&A discussion. 1. The value and challenges of RWD as a source for...
IND 14-1 10 min Detection and characterization of liver cancer: which agent and when? Alain Luciani, Creteil / France Importance of contrast enhanced MRI in detection for the liver cancer, similarities and differences between Hepatobiliary Contrast agents. IND...
Recent Comments